VUNO Seeking 'Arab Health 2024'... "Accelerating Overseas Expansion"

Medical AI company VUNO announced on the 23rd that it will participate in the medical device exhibition "Arab Health 2024," held in Dubai, United Arab Emirates (UAE), from the 29th of this month to the 1st of next month.

Arab Health is the largest medical device exhibition in the Middle East, held annually since 1976, marking its 49th edition this year. More than 100,000 hospital officials and buyers participate each year to share the latest trends in medical technology and exchange business information. This year, over 3,400 companies from more than 180 countries are expected to participate.

VUNO will showcase its key products in the fields of medical imaging and biosignals at Arab Health 2024, which it is attending for the first time. The exhibition items include five products in the medical imaging field: VUNO Med-DeepBrain, VUNO Med-CT AI, VUNO Med-Chest X-ray, VUNO Med-Fundus AI, and VUNO Med-BoneAge, along with the home-use electrocardiogram (ECG) medical device HATIV P30.

VUNO plans to actively seek new business opportunities through meetings with buyers and company representatives from various countries attending the event. It will promote the overseas achievements of products such as VUNO Med-DeepBrain, which is preparing to enter the U.S. market, and VUNO Med-Chest CT AI, an auxiliary product for chest computed tomography (CT) analysis sold in Japan. The company will also provide detailed business strategies for each product, including the home-use medical device HATIV P30, which has entered the consumer market in a business-to-consumer (B2C) format. Additionally, VUNO intends to share key research results of each product introduced in global academic journals and future update plans.

Lee Yeha, CEO of VUNO, said, “Arab Health is a large-scale event attended by buyers and industry officials from around the world beyond the Middle East, so we expect it to be a great opportunity to secure new partnerships. We will strive to actively promote the clinical efficacy and use cases of each product entering various national medical markets to accelerate our expansion into overseas markets.”

This content was produced with the assistance of AI translation services.